Bone mineral density analysis in patients with primary hyperparathyroidism associated with multiple endocrine neoplasia type 1 after total parathyroidectomy


Autoria(s): COUTINHO, Flavia L.; LOURENCO JR., Delmar M.; TOLEDO, Rodrigo A.; MONTENEGRO, Fabio L. M.; CORREIA-DEUR, Joya E. M.; TOLEDO, Sergio P. A.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

19/10/2012

19/10/2012

2010

Resumo

P>Objective Limited data have been reported on the effect of parathyroidectomy (PTx) on bone mineral density (BMD) in the setting of patients with hyperparathyroidism (HPT) associated with multiple endocrine neoplasia type 1 (MEN1). This study investigates the impact of total PTx on BMD in patients with HPT/MEN1. Design and patients A case series study was performed in a tertiary academic hospital. A total of 16 HPT/MEN1 patients from six families harbouring MEN1 germline mutations were subjected to total PTx followed by parathyroid auto-implant in the forearm. Measurements Bone mineral density values were assessed using dual-energy X-ray absorptiometry. Results Before PTx, reduced BMD (Z-score <-2 center dot 0) was highly prevalent in the proximal one-third of the distal radius (1/3 DR) (50%), lumbar spine (LS) (43 center dot 7%), ultradistal radius (UDR) (43 center dot 7%), femoral neck (FN) (25%) and total femur (TF) (18 center dot 7%) in the patients. Fifteen months after PTx, we observed a BMD improvement in the LS (from 0 center dot 843 to 0 center dot 909 g/cm2; +8 center dot 4%, P = 0 center dot 001), FN (from 0 center dot 745 to 0 center dot 798 g/cm2; +7 center dot 7%, P = 0 center dot 0001) and TF (from 0 center dot 818 to 0 center dot 874 g/cm2; +6 center dot 9%, P < 0 center dot 0001). No significant change was noticed in the 1/3 DR and UDR after PTx. Conclusions This data confirmed BMD recovery in the LS and FN after PTx in HPT/MEN1 patients. We also documented a significant BMD increase in the TF and no change in both the 1/3 DR and UDR BMD after PTx. Our data suggest that LS and proximal femur are the most informative sites to evaluate the short-term BMD outcome after PTx in HPT/MEN1 subjects.

Sao Paulo State Research Foundation, FAPESP[02/09860-8]

CAPES fellowships

Fundacao Faculdade de Medicina (FFM)

Identificador

CLINICAL ENDOCRINOLOGY, v.72, n.4, p.462-468, 2010

0300-0664

http://producao.usp.br/handle/BDPI/23082

10.1111/j.1365-2265.2009.03672.x

http://dx.doi.org/10.1111/j.1365-2265.2009.03672.x

Idioma(s)

eng

Publicador

WILEY-BLACKWELL PUBLISHING, INC

Relação

Clinical Endocrinology

Direitos

restrictedAccess

Copyright WILEY-BLACKWELL PUBLISHING, INC

Palavras-Chave #3RD INTERNATIONAL WORKSHOP #SURGERY #MEN1 #GUIDELINES #MUTATIONS #DIAGNOSIS #SEVERITY #FAMILIES #RECOVERY #SKELETON #Endocrinology & Metabolism
Tipo

article

original article

publishedVersion